Free Trial

Soleno Therapeutics (SLNO) Earnings Date, Estimates & Call Transcripts

Soleno Therapeutics logo
$57.05 -0.06 (-0.11%)
(As of 11/8/2024 ET)

Soleno Therapeutics Latest Earnings Summary

Upcoming
Earnings Date
Mar. 5Estimated
Actual EPS
(Aug. 7)
-$0.57 Beat By $0.06
Consensus EPS
(Aug. 7)
-$0.63

Soleno Therapeutics announced Q2 2024 earnings on August 7, 2024, reporting an EPS of -$0.57, which beat the consensus estimate of -$0.63 by $0.06. With a trailing EPS of -$2.44, Soleno Therapeutics' earnings are expected to grow next year, from ($2.29) to ($2.25) per share.

SLNO Upcoming Earnings

Soleno Therapeutics' next earnings date is estimated for Wednesday, March 5, 2025, based off prior year's reporting schedules.

Get Soleno Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Soleno Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SLNO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SLNO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Soleno Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20241-$0.56-$0.56-$0.56
Q4 20241-$0.60-$0.60-$0.60
20242-$1.16-$1.16-$1.16
Q1 20251-$0.59-$0.59-$0.59
Q2 20251-$0.59-$0.59-$0.59
Q3 20251-$0.61-$0.61-$0.61
Q4 20251-$0.53-$0.53-$0.53
FY 20254($2.32)($2.32)($2.32)

Soleno Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/5/2025
(Estimated)
------- 
8/7/2024--$0.63-$0.57+$0.06-$0.57--  
5/9/2024Q1 2024-$0.30-$0.59 -$0.29-$0.59--  
3/6/2024Q4 2023-$0.31-$0.33 -$0.02-$0.33--  
11/7/2023Q3 2023-$0.62-$0.95 -$0.33-$0.95--  
8/8/2023Q2 2023-$0.70-$0.81 -$0.11-$0.81--  
5/9/2023Q1 2023-$0.71-$0.88 -$0.17-$0.88--  
3/21/2023Q4 2022-$0.76-$0.58+$0.18-$0.58--  
11/9/2022Q3 2022-$1.05-$0.76+$0.29-$0.76--  

Soleno Therapeutics Earnings - Frequently Asked Questions

Soleno Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates. Learn more on SLNO's earnings history.

In the previous quarter, Soleno Therapeutics (NASDAQ:SLNO) reported ($0.57) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.63) by $0.06. Learn more on analysts' earnings estimate vs. SLNO's actual earnings.

Soleno Therapeutics (NASDAQ:SLNO) has a recorded net income of -$38.99 million. SLNO has generated -$2.44 earnings per share over the last four quarters.

Soleno Therapeutics's earnings are expected to grow from ($2.29) per share to ($2.25) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:SLNO) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners